Results 91 to 100 of about 21,607,700 (130)

Preparation of C-reactive protein latex reagent of human serum

, 2006
C-reactive protein (CRP) is an acute phase reactant the concentration of which increases significantly following tissue injury or inflammation. It is present in the albumin fraction of the serum of patients and is antigenic upon injection into rabbits ...
Sabar, Muna, Mahdi, Layla K., Alshalchi, Sahar A.   +2 more
core   +1 more source

Monomeric C-Reactive Protein Aggravates Secondary Degeneration after Intracerebral Haemorrhagic Stroke and May Function as a Sensor for Systemic Inflammation. [PDF]

J Clin Med, 2020
Slevin M, García-Lara E, Capitanescu B, Sanfeliu C, Zeinolabediny Y, AlBaradie R, Olah P, Guo B, Pirici D, Di Napoli M, Popa-Wagner A.   +10 more
europepmc   +1 more source

Metabolic syndrome and C-reactive protein in bank employees

, 2016
Monica Cattafesta,1 Nazaré Souza Bissoli,2 Luciane Bresciani Salaroli,1,31Postgraduate Program in Nutrition and Health, 2Postgraduate Program in Physiological Sciences, 3Postgraduate Program in Public Health, Department of Health Integrated ...
Bissoli NS, Salaroli LB, Cattafesta M
core  

Two Forms of C-Reactive Protein and Their Implication for Atherogenesis: Focus on Monomeric Form

Journal of Angiotherapy
In this review, we discuss the role of C-reactive protein (CRP), a biomarker of inflammation, in the development of atherosclerosis. CRP exists in two forms: the native pentameric form (nCRP) and the non-native form (mCRP), which is formed during inflammatory processes. The article explores the functions of both forms in atherosclerosis.
openaire   +1 more source

Microglial pro-inflammatory mechanisms induced by monomeric C-reactive protein are counteracted by soluble epoxide hydrolase inhibitors. [PDF]

Int Immunopharmacol
Bartra C, Vuraić K, Yuan Y, Codony S, Valdés-Quiroz H, Casal C, Slevin M, Máquez-Kisinousky L, Planas AM, Griñán-Ferré C, Pallàs M, Morisseau C, Hammock BD, Vázquez S, Suñol C, Sanfeliu C.   +15 more
europepmc   +1 more source

Monomeric C-Reactive Protein Potential Utilization in the Histological Assessment of Inflammatory Bowel Disease (IBD) Patients. [PDF]

Cureus
Muresan S, Slevin M, Szasz E, Loghin A.
europepmc   +1 more source

Deposition of monomeric C-reactive protein as evidence of localised neurodegenerative diseases

Bioscience Biotechnology Research Communications, 2016
Al Hsinawi M, Al Baradie R
openaire   +1 more source

Brain Vascular Expression of Monomeric C-Reactive Protein Is Blocked by C10M Following Intraperitoneal Injection in an ApoE-/- Murine Model of Dyslipidemia: An Immunohistochemical Analysis. [PDF]

Cureus
Pastorello Y, Russo AP, Bănescu C, Caprio V, Gáll Z, Potempa L, Cordoș B, Di Napoli M, Slevin M.   +8 more
europepmc   +1 more source

Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease. [PDF]

J Cardiovasc Transl Res, 2016
Crawford JR, Trial J, Nambi V, Hoogeveen RC, Taffet GE, Entman ML.   +5 more
europepmc   +1 more source

Monomeric C-reactive protein--a key molecule driving development of Alzheimer's disease associated with brain ischaemia? [PDF]

Sci Rep, 2015
Slevin M, Matou S, Zeinolabediny Y, Corpas R, Weston R, Liu D, Boras E, Di Napoli M, Petcu E, Sarroca S, Popa-Wagner A, Love S, Font MA, Potempa LA, Al-Baradie R, Sanfeliu C, Revilla S, Badimon L, Krupinski J.   +18 more
europepmc   +1 more source